The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers

Psychopharmacology

Volumn 138, Issue 2, 1998, Pages 190-197

  Van Berckel, B N M ^a   Lipsch, C ^a   Gispen de Wied, C ^a   Wynne, H J ^b   Blankenstein, M A ^a   Van Ree, J M ^c   Kahn, R S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cortisol; D Cycloserine; Glutamate; Human; LH; NMDA; Schizophrenia

Indexed keywords

CYCLOSERINE; GLUTAMIC ACID; HYDROCORTISONE; HYPOPHYSIS HORMONE; LUTEINIZING HORMONE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; PARTIAL AGONIST; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE RELEASE; HYPOPHYSIS FUNCTION; LUTEINIZING HORMONE RELEASE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA;

ADULT; AFFECT; ANTIPSYCHOTIC AGENTS; BEHAVIOR; BLOOD PRESSURE; BODY TEMPERATURE; BRIEF PSYCHIATRIC RATING SCALE; CROSS-OVER STUDIES; CYCLOSERINE; DOPAMINE; DOUBLE-BLIND METHOD; HEART RATE; HOMOVANILLIC ACID; HUMANS; HYDROCORTISONE; LUTEINIZING HORMONE; MALE; N-METHYLASPARTATE; NEUROSECRETORY SYSTEMS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 0031818722     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050662     Document Type: Article

References (79)

1. Abbud R, Smith MS (1995) Do GnRH neurons express the gene for the NMDA receptor? Brain Res 690:117-120
2. Andreasen NC (1985) Comprehensive assessment of symptoms and history (CASH). University of Iowa, Iowa City
3. Arslan M, Pohl CR, Plant TM (1988) DL-2-Amino-5-phosphonopentanoic acid, a specific N-methyl-D-aspartic acid receptor antagonist, suppresses pulsatile LH release in the rat. Neuroendocrinology 47:465-468
4. 3H]M K-binding to N-methyl-D-aspartate receptors solubilized from rat brain: effects of glycine site ligands, polyamines, ifenprodil, and desipramine. J Neurochem 57:39-45
5. Barraclough CA, Wise PM (1982) The role of catecholamines in the regulation of pituitary luteinizing hormone and follicle-stimulating hormone secretion. Endocr Rev 3:91-119
6. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211-218
7. Bourguignon JP, Gerard A, Franchimont P (1989) Direct activation of gonadotropin-releasing hormone secretion through different receptors to neuroexcitatory amino acids. Neuroendocrinology 49:402 408
8. Brambilla F (1980) Neuroendocrine function in schizophrenia. Acta Psychiatr Belg 80:421-435
9. Brann DW (1995) Glutamate: a major excitatory transmitter in neuroendocrine regulation. Neuroendocrinology 61:213-225
10. Brann DW, Mahesh VB (1992) Excitatory amino acid regulation of gonadotropin secretion: modulation by steroid hormones. J Steroid Biochem Mol Biol 41:847-850
11. Brann DW, Mahesh VB (1994) Excitatory amino acids: function and significance in reproduction and neuroendocrine regulation. Front Neuroendocrinol 15:3-49
12. Brann DW, Mahesh VB (1995) Glutamate: a major neuroendocrine excitatory signal mediating steroid effects on gonadotropin secretion. J Steroid Biochem Mol Biol 53:325-329
13. Cantalamessa L, Catania A, Silva A, Orsatti A, Baldini M, Mosca G, Zanussi C, Cazzullo CL (1984) Gonadotropin response to gonadotropin releasing hormone in acute schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 8: 411-417
14. Carbone S, Szwarcfarb B, Rondina D, Feleder C, Moguilevsky JA (1996) Differential effects of the N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors of the excitatory amino acids system on LH and FSH secretion. Its effects on the hypothalamic luteinizing hormone releasing hormone during maturation in male rats. Brain Res 707:139 145
15. Chapman AG (1992) Effects of NMDA antagonists and non-NMDA antagonists in experimental models of epilepsy. In: Simon RP (ed) Excitatory amino acids. Thieme, New York, pp 165-272
16. Chessell IP, Procter AW, Francis PT, Bowen DM (1991) D-cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-D-aspartate receptor-ionophore complex in Alzheimer brain. Brain Res 565:345-348
17. Cicero TJ, Meyer ER, Bell RD (1988) Characterization and possible opioid modulation of N-methyl-D-aspartic acid induced increases in serum luteinizing hormone levels in the developing male rat. Life Sci 42:1725-1732
18. Cotman CW, Geddes J, Bridges R, Monaghan D (1989) NMDA receptors and Altzheimer disease. Neurobiol Aging 10:603 605
19. Emmett MR, Mick SJ, Cler JA, Rao TS, Iyengar S, Wood PL (1991) Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo. Neuropharmacology 30:1167-1171
20. Endicott J, Spitzer RL (1978) Diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 35:837 844
21. Ferin M, Carmel PW, Warren MP, Himsworth RL, Frantz AG, Nocenti MR (1976) Phencyclidine sedation as a technique for handling rhesus monkeys: effects on LH, GH, and prolactin secretion. Proc Soc Exp Biol Med 151:428-433
22. Ferrier IN, Johnstone EC, Crow TJ, Rincon Rodriguez I (1983) Anterior pituitary hormone secretion in chronic schizophrenics. Arch Gen Psychiatry 40:755-761
23. Gao XM, Chen LW, Tamminga CA (1997) Blockade of phencyclidine-and MK-induced regional zif268 mRNA expression (abstract) Schizophr Res 24:76
24. Glazer WM, Charney DS, Heninger GR (1987) Noradrenergic function in schizophrenia. Arch Gen Psychiatry 44:898-904
25. Goff DC, Tsai GC, Manoach DS, Coyle JT (1995) Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry 152:1213-1215
26. Gore AC, Roberts JL (1994) Regulation of gonadotropin-releasing hormone gene expression by the excitatory amino acids kainic acid and N-methyl-D,L-aspartate in the male rat. Endocrinology 134:2026-2031
27. Henn FA (1995) The NMDA receptor as a site for psychopathology primary or secondary role? Arch Gen Psychiatry 52: 1008 1010
28. Hui Y, Hastings MH, Maywood ES, Ebling FJ (1992) Photoperiodic regulation of glutamatergic stimulation of secretion of luteinizing hormone in male Syrian hamsters. J Reprod Fertil 95:935 946
29. Ishimaru M, Kurumaji A, Toru M (1994) Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics evidence for glutamate hypothesis. Biol Psychiatry 35:84-95
30. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia [see comments]. Am J Psychiatry 148:1301 1308
31. Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer J (1994) Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 151:1234 1236
32. Jezova D, Oliver C, Jurcovicova J (1991) Stimulation of adrenocorticotropin but not prolactin and catecholamine release by N-methyl-aspartic acid. Neuroendocrinology 54:488-492
33. Kahn RS, Wetzler S (1991) m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 30:1139-1166
34. Kulra SP, Crowley WR (1992) Neuropeptide Y: a novel neuroendocrine peptide in the control of pituitary hormone secretion, and its relation to luteinizing hormone. Front Neuroendocrinol 13:1-46
35. Kretschmer BD, Bubser M, Schmidt WJ (1995) Behavioral and neurochemical actions of the strychnine-insensitive glycine receptor antagonist, 7-chlorokynurenate, in rats. Eur J Pharmacol 280:37-45
36. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214
37. Lahti AC, Koffel B, Laporte D, Tamminga CA (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9-19
38. Lanthorn TH (1994) D-Cycloserine: agonist turned antagonist. Amino Acids 6:247 260
39. Lipton SA, Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurological disorders. N Engl J Med 330:613-622
40. Luby ED, Gottlieb JS, Cohen BD, Rosenbaum G, Domino EF (1962) Model psychoses and schizophrenia. Am J Psychiatry 119:61-67
41. Mandell GL and Petri WAJ (1996) Drugs used in the chemotherapy of tubercuclosis, Mycobacterium avium complex disease, and leprosy. In: Goodmann LS, Gillmann A (eds) The pharmacological basis of therapeutics, 9th edn. McGraw-Hill, New York. pp 1164-1165
42. Mason GA, Bissette G, Nemeroff CB (1983) Effects of excitotoxic amino acids on pituitary hormone secretion in the rat. Brain Res 289:366-369
43. Mcallister KH (1994) D-cycloserine enhances social behaviour in individually-housed mice in the resident-intruder test. Psychopharmacology 116:317-325
44. Medhamurthy R, Gay VL, Plant TM (1992) Repetitive injections of L-glutamic acid, in contrast to those of N-methyl-D,L-aspartic acid, fail to elicit sustained hypothalamic GnRH release in the prepubertal male rhesus monkey (Macaca mulatta). Neuroendocrinology 55:660-666
45. 3H]kainic acid binding in the prefrontal cortex in schizophrenia. Neurosci Lett 40:245 250
46. Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007
47. Ondo JG, Wheeler DD, Dom RM (1988) Hypothalamic site of action for N-methyl-D-aspartate (NMDA) on LH secretion. Life Sci 43:2283-2286
48. Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10:799-812
49. Paschen W (1996) Glutamate excitotoxicity in transient global cerebral ischemia. Acta Neurobiol Exp 56:313-322
50. Peterson SL, Schwade ND (1993) The anticonvulsant activity of D-cycloserine is specific for tonic convulsions. Epilepsy Res 15:141-148
51. Petersen SL, McCrone S, Keller M, Gardner E (1991) Rapid increase in LHRH mRNA levels following NMDA. Endocrinology 129:1679-1681
52. Ping L, Mahesh VB, Brann DW (1995) Effect of NMDA and non-NMDA receptor antagonists on pulsatile luteinizing hormone secretion in the adult male rat. Neuroendocrinology 61:226 234
53. Pitkanen M, Sirvio J, Lahtinen H, Koivisto E, Riekkinen P (1994) D-Cycloserine, a partial agonist at the glycine site, enhances the excitability of dentate granule cells in vivo in rats. Eur J Pharmacol 253:125 129
54. Pitkanen M, Sirvio J, Macdonald E, Niemi S, Ekonsalo T, Riekkinen P (1996) The effects of D-cycloserine and mk-on the performance of rats in two spatial learning and memory tasks. Eur Neuropsychopharmacol 5:457 463
55. Pittaluga A, Fedele E, Risiglione C, Raiteri M (1993) Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine. Eur J Pharmacol 231:129-134
56. Priestley T, Laughton P, Myers J, Le Bourdelles B, Kerby J, Whiting PJ (1995) Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Mol Pharmacol 48:841-848
57. Puri CP, Puri V, Anand Kumar TC (1981) Serum levels of testosterone, cortisol, prolactin and bioactive luteinizing hormone in adult male rhesus monkeys following cage-restraint or anaesthetizing with ketamine hydrochloride. Acta Endocrinol Copenh 97:118 124
58. Quartermain D, Mower J, Rafferty MF, Herting RL, Lanthorn TH (1994) Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention. Eur J Pharmacol 257:7-12
59. Rivas Salazar JL (1970) On cycloserine in the treatment of pulmonary tuberculosis and its use for postoperative protection. Scand J Respir Dis Suppl 71:314-324
60. Rothstein JD (1995) Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis. Adv Neurol 68:7-20
61. Saulskaya N, Marsden CA (1995) Conditioned dopamine release: dependence upon N-methyl-D-aspartate receptors. Neuroscience 67:57-63
62. Schainker BA, Cicero TJ (1980) Acute central stimulation of luteinizing hormone by parenterally administered N-methyl-D,L-aspartic acid in the male rat. Brain Res 184:425-437
63. Schuster GM, Schmidt WJ (1992) D-Cycloserine reverses the working memory impairment of hippocampal lesioned rats in a spatial learning task. Eur J Pharmacol 224:97-98
64. Siris SG, Siris ES, Van Kammen DP, Docherty JP, Alexander PE, Bunney WEJ (1980) Effects of dopamine blockade on gonadotropins and testosterone in men. Am J Psychiatry 137:211-214
65. Suh J, Song ES, Kim C, Yu MH, Kim K (1994) Cross-talk between N-methyl-D-aspartate and adrenergic neurotransmission in the regulation of hypothalamic GnRH gene expression. Brain Res 645:36-40
66. Thijssen JH, Wood WG, Kessler AC, Griesser HW, Bauer O, Bieglmayer C, Eugui J, Mirabel JL, Gaessler H, Klinga K, Koettgen E, Mueller C, Messeri G, Neumeier D, Luppa D, Roger H, Castagnier M, Cervast G, Pernott P, Seth J, Gow S, Hanning J (1991) Multicenter evaluation of new enzyme-linked immunoassays of follitropin and lutropin in serum or plasma. Clin Chem 37:1257-1263
67. Thompson LT, Moskal JR, Disterhoft JF (1992) Hippocampus-dependent learning facilitated by a monoclonal antibody or D-cycloserine. Nature 359:638-641
68. Toru M, Watanabe S, Shibuya H, Nishikawa T, Noda K, Mitsushio H, Ichikawa H, Kurumaji A, Takashima M, Mataga N, Ogawa A (1988) Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatr Scand 78:121-137
69. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT (1995) Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 52:829-836
70. van Berckel BNM, Hijman R, van der Linden JA, Westenberg HGM, van Ree JM, Kahn RS (1996) Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients. Biol Psychiatry 40:1298-1300
71. van Berckel BNM, Lipsch C, Timp S, Gispen de Wied CC, Wynne HJ, van Ree JM, Kahn RS (1997) Behavioral and neuroendocrine effects of the partial NMDA agonist D-cycloserine in healthy subjects. Neuropsychopharmacology 16:317-324
72. van den Pol AN, Wuarin JP, Dudek FE (1990) Glutamate, the dominant excitatory transmitter in neuroendocrine regulation Science 250:1276-1278
73. Veldhuis JD, Winters SJ (1989) Nature of alpha subunit secretion in men: circadian rhythms, pulsatile release and secretory profiles. J Androl 10:248-258
74. Veldhuis JD, Johnson ML, Iranmanesh A, Lizarralde G (1994) Rhythmic and nonrhythmic modes of anterior pituitary hormone release in man. In: Touitou Y, Haus E (eds) Biological rhythms in clinical & laboratory medicine, 2nd edn. Springer, Berlin Heidelberg New York, pp 277-291
75. Vitale ML, Chiocchio SR (1993) Serotonin, a neurotransmitter involved in the regulation of luteinizing hormone release Endocr Rev 14:480-493
76. Walker WC, Murdoch JM (1957) Cycloserine in the treatment of pulmonary tuberculosis. A report on toxicity. Tubercle Lond 38:297
77. Watson GB, Bolanowski MA, Baganoff MP, Deppeler CL, Lanthorn TH (1990) D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes. Brain Res 510:158-160
78. Westenberg HGM, Verhoeven WMA (1988) CSF monoamine metabolites in dementia of altzheimer type and controls: evidence for lower level of homovanillic acid and 5-hydroxyindole acetic acid in patients. Int J Geriatr Psychiatry 3:281-288
79. Wlaz P, Baran H, Loscher W (1994) Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of mk-in mice. Eur J Pharmacol 257:217 225